Ptc Therapeutics Inc (PTCT)

Jan 18, 2025

PTC Therapeutics Stock Soars on Novartis Licensing Agreement - MSN

Jan 18, 2025

Jan 18, 2025

Assenagon Asset Management S.A. Sells 52,794 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jan 18, 2025

Jan 16, 2025

Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail

Jan 16, 2025

Jan 16, 2025

William Blair Boosts Earnings Estimates for PTC Therapeutics - MarketBeat

Jan 16, 2025

Jan 16, 2025

PTC Therapeutics' SWOT analysis: rare disease biotech stock faces pivotal year - Investing.com Australia

Jan 16, 2025

Jan 15, 2025

Cantor Fitzgerald Issues Pessimistic Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat

Jan 15, 2025

Jan 14, 2025

PTC Therapeutics sees several potential catalysts in 2025 - MSN

Jan 14, 2025

Jan 14, 2025

Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI™ (eladocagene exuparvovec-tneq) - Yahoo Finance

Jan 14, 2025

Jan 14, 2025

Muscular Dystrophy Treatment Market Next Big Thing Forecast By 2031 | Santhera Pharmaceuticals, PTC Therapeutics - openPR

Jan 14, 2025

Jan 13, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jan 13, 2025

Jan 13, 2025

PTC Therapeutics Surpasses Revenue Guidance for 2024 - TipRanks

Jan 13, 2025

Jan 13, 2025

PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals - Investing.com

Jan 13, 2025

Jan 13, 2025

PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals By Investing.com - Investing.com South Africa

Jan 13, 2025

Jan 13, 2025

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference - Longview News-Journal

Jan 13, 2025

Jan 11, 2025

Ptc Therapeutics' chief accounting officer sells $132,492 in stock - Investing.com India

Jan 11, 2025

Jan 11, 2025

Ptc Therapeutics' chief accounting officer sells $132,492 in stock By Investing.com - Investing.com South Africa

Jan 11, 2025

Jan 11, 2025

PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock By Investing.com - Investing.com South Africa

Jan 11, 2025

Jan 11, 2025

Ptc Therapeutics exec VP sells shares worth $158,870 By Investing.com - Investing.com Australia

Jan 11, 2025

Jan 11, 2025

Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock - Investing.com India

Jan 11, 2025

Jan 11, 2025

Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock By Investing.com - Investing.com Australia

Jan 11, 2025

Jan 10, 2025

Ptc Therapeutics exec VP sells shares worth $158,870 - Investing.com India

Jan 10, 2025

Jan 10, 2025

Ptc therapeutics' EVP sells $90,036 in stock By Investing.com - Investing.com Australia

Jan 10, 2025

Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Lee Scott Golden Sells 810 Shares - MarketBeat

Jan 10, 2025

Jan 10, 2025

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) VP Sells 1,543 Shares of Stock - MarketBeat

Jan 10, 2025

Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 1,291 Shares - MarketBeat

Jan 10, 2025

Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 1,265 Shares - MarketBeat

Jan 10, 2025

Jan 10, 2025

Ptc therapeutics’ EVP sells $90,036 in stock By Investing.com - Investing.com Nigeria

Jan 10, 2025

Jan 10, 2025

PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock - Investing.com

Jan 10, 2025

Jan 10, 2025

Ptc Therapeutics executive Neil Almstead sells shares worth $133,674 - Investing.com

Jan 10, 2025

Jan 10, 2025

Ptc therapeutics' EVP sells $90,036 in stock - Investing.com

Jan 10, 2025

Jan 09, 2025

JPMorgan Chase & Co. Cuts Stock Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jan 09, 2025

Jan 07, 2025

Denali Suffers Another ALS Fail With Phase II/III Flop - BioSpace

Jan 07, 2025

Jan 07, 2025

Have Insiders Sold PTC Therapeutics Shares Recently? - Simply Wall St

Jan 07, 2025

Jan 06, 2025

Where are the Opportunities in (PTCT) - Stock Traders Daily

Jan 06, 2025

Jan 04, 2025

Ptc Therapeutics CEO Matthew Klein sells $373,879 in stock By Investing.com - Investing.com Australia

Jan 04, 2025

Jan 04, 2025

Ptc Therapeutics CEO Matthew Klein sells $373,879 in stock - Investing.com India

Jan 04, 2025

Jan 03, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) CEO Matthew B. Klein Sells 8,279 Shares - MarketBeat

Jan 03, 2025

Jan 03, 2025

PTC Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation - Quantisnow

Jan 03, 2025

Dec 29, 2024

Brokerages Set PTC Therapeutics, Inc. (NASDAQ:PTCT) Price Target at $54.08 - MarketBeat

Dec 29, 2024

Dec 27, 2024

Long Term Trading Analysis for (PTCT) - Stock Traders Daily

Dec 27, 2024

Dec 25, 2024

PTC Therapeutics Stock Eyes Further Rally After Price-Target Hikes On Huntington’s Therapy Deal With Novartis: Retail Buzz Grows - MSN

Dec 25, 2024

Dec 23, 2024

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion - MSN

Dec 23, 2024

Dec 23, 2024

PTC Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Dec 23, 2024

Dec 22, 2024

Geode Capital Management LLC Acquires 10,886 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Dec 22, 2024

Dec 20, 2024

PTC upgraded to outperform by RBC on Novartis deal - MSN

Dec 20, 2024